Navigation Links
VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial
Date:2/6/2008

al vectors, lentiviral vectors appear to sustain expression of the delivered genes of interest for a longer period of time. Their safety profiles are currently being evaluated in clinical trials.

"These results are everything we've been hoping for," said Dr. Riku Rautsola, CEO and President of VIRxSYS. "VRX496 is a remarkably promising treatment for HIV. We are very excited about what we are seeing so far in our trials and are confident that these results will continue into Phase III."

The VIRxSYS results were presented at CROI on Tuesday, February 5th from 1-4 PM at session 124 in Hall A. The VIRxSYS poster was number 753.

About VIRxSYS

VIRxSYS is a private biotechnology company using proprietary lentiviral vector delivery and RNA payload platforms to develop therapies for serious human diseases. The Company's initial lentiviral delivery technology was exclusively licensed from The Johns Hopkins University and has been substantially advanced in the Company's laboratories. The RNA payload technology was acquired and has been integrated with the Company's lentiviral delivery technology. In addition to preclinical programs for genetic and other serious diseases, the Company is currently developing gene and vaccine therapies for HIV, one of which has advanced to Phase 2 human clinical trials. More information regarding VIRxSYS can be found at http://www.virxsys.com. Details for the Phase II study can be found at the NIH clinical trials website at clinicaltrials.gov/show/NCT00131560.

Contact: Paul Gibney

Phone: (212) 255-5340

E-mail: pgibney@corinthgroup.com


'/>"/>
SOURCE VIRxSYS Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VIRxSYS and Lentigen Announce Litigation Settlement
2. Exelixis Announces February 12 Webcast of Presentation at the 10th Annual BIO CEO and Investor Conference
3. Global Probiotics Council Announces Young Investigator Grant for Probiotics Research to Fund the Next Generation of Gut Microbiota Research
4. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
5. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
6. Xenon Announces Appointment of VP, Discovery Research
7. BioSpecifics Technologies Corp. Announces Repayment of Outstanding Loan
8. Wyeth Announces Election of Timothy P. Cost as Senior Vice President, Corporate Affairs
9. Finkelstein Thompson LLP Announces Filing of Securities Fraud Class Action Against CellCyte Genetics Corporation
10. DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results
11. Physicians Reference Laboratory Announces New Diagnostic for Womens Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... DIEGO, California, USA (PRWEB) August 28, 2014 ... the Department of Physics and Optical Science and Director ... the University of North Carolina at Charlotte, and co-founder ... been elected to serve as the 2015 Vice President ... , SPIE 2014 President Philip Stahl announced recent election ...
(Date:8/28/2014)... Ind. A new research platform uses ... of tiny structures undergoing stress and heating, ... improve designs for microelectronics and batteries., This ... information about how heating and the surface ... properties. Researchers have discussed the merits of ...
(Date:8/28/2014)... , Aug. 28, 2014  Next month, executives from clinical ... key industry events beginning with Patient-Centered Clinical Trials 2014 ... Boston , September 4-5. Patient recruitment experts ... Aaron Fleishman will share insights on the benefits ... variety of tactics – from media to mobile apps – ...
(Date:8/28/2014)... new work by a Florida State University research team ... take your temperature, emit white light, and convert photon ... looks like a butterfly. , Biwu Ma, associate professor ... the FAMU-FSU College of Engineering, created the molecule in ... to discover that his creation has many other unique ...
Breaking Biology Technology:Glenn Boreman, UNC Professor and Plasmonics Co-Founder, Elected to SPIE Presidential Chain 2New analytical technology reveals 'nanomechanical' surface traits 2New analytical technology reveals 'nanomechanical' surface traits 3BBK Worldwide Leads Sessions at Key September Events 2Novel 'butterfly' molecule could build new sensors, photoenergy conversion devices 2
... have created living computers by genetically altering bacteria. The ... access Journal of Biological Engineering, demonstrate that computing in ... number of applications including data storage and as a ... research team from the biology and the mathematics departments ...
... Amarin Corporation,plc (NASDAQ: AMRN ) ("Amarin" or ... full year ended December 31, 2007. For the,fourth quarter ... million, or,$0.72 per share, compared with a net loss ... quarter of 2006. The increase in net loss for ...
... pork processing ... industries, ... Board: TKER), a distributor and marketer of proprietary,technology effective in inhibiting ... Safety and Inspection,Service ("FSIS") of the United States Food and Drug ...
Cached Biology Technology:Researchers bring new meaning to the term 'computer bug' 2Amarin Announces Financial Results for Fourth Quarter and Full Year 2007 2Amarin Announces Financial Results for Fourth Quarter and Full Year 2007 3Amarin Announces Financial Results for Fourth Quarter and Full Year 2007 4Amarin Announces Financial Results for Fourth Quarter and Full Year 2007 5Amarin Announces Financial Results for Fourth Quarter and Full Year 2007 6Amarin Announces Financial Results for Fourth Quarter and Full Year 2007 7Amarin Announces Financial Results for Fourth Quarter and Full Year 2007 8Amarin Announces Financial Results for Fourth Quarter and Full Year 2007 9Tasker Products Receives Authorization from USDA for its Tasker Clear for use in Meat and Pork Industries 2Tasker Products Receives Authorization from USDA for its Tasker Clear for use in Meat and Pork Industries 3
(Date:8/29/2014)... Researchers at UC Davis have made some surprising ... infection. Studying simian immunodeficiency virus (SIV), the team ... Paneth cells are early responders to viral invasion ... producing a cytokine called interleukin-1 beta (IL-1β). ... IL-1β causes breakdown of the gut epithelium that ...
(Date:8/29/2014)... Dartmouth researchers explored the type and number of connections ... assortativity plays on robustness in a study published in ... study found that the assortativity signature contributes to a ... seems that varying the out-out assortativity of TFN models ... of the other three types of assortativity," said Dov ...
(Date:8/29/2014)... fold them: modern materials that are light, flexible and ... skin or electronic paper. , Making such concepts affordable ... new way of working with copper nanowires and a ... Previous success in the field of ultra-lightweight "aerogel monoliths" ... and silver nanowires. , By turning instead to ...
Breaking Biology News(10 mins):The early cost of HIV 2Assortativity signatures of transcription factor networks contribute to robustness 2Copper shines as flexible conductor 2
... used in heated automobile seats, gadgets that charge iPhones from ... a renaissance and could well emerge as a new "green" ... roles in addressing some of society,s most pressing sustainability issues. ... termed thermoelectrics in the current issue of Chemical ...
... Elsevier, a world-leading provider of scientific, technical and ... Australian Society for Parasitology, is pleased to announce the ... Parasitology: Drugs and Drug Resistance . The new electronic ... parasitology journal, International Journal for Parasitology, and ...
... infect rate in Hong Kong this year. So far, 466 children ... by Streptococcus pyogenes, a gram-positive pathogen that can be ... guidance of Hong Kong Center for Disease Control (HK CDC), Hong ... sequence of the S. pyogenes strain that was isolated ...
Cached Biology News:Elsevier launches International Journal for Parasitology: Drugs and Drug Resistance 2Hong Kong University leads the genomics research of scarlet fever pathogen 2
...
Coverslips for Microarrays, 1. *Category: MICROARRAY ACCESSORIES....
S. O'Hare & C.K. Atterwill • In vitro toxicity techniques for regular lab use. Ex vivo techniques are also covered with the aim of reducing and refining the use of animals in the future....
... 2'-O-Methyltransferase converts Cap 0 (or Cap 0-like) ... 1 structure has been shown to increase ... 50%. This improvement is seen in Cap ... Capping System as well as those Cap ...
Biology Products: